Literature DB >> 10649740

Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate.

N Fassinger1, S Dabbagh, S Mukhopadhyay, D Y Lee.   

Abstract

Options for the management of infants with hyperkalemia secondary to renal insufficiency are limited for infants not maintained on dialysis. Precipitation of potassium (K+) from infant formula with sodium polystyrene sulfonate (KX) prior to feeding has been reported. However, its effect on calcium (Ca2+) and sodium (Na+) has not been quantitatively defined. The purpose of this study was to examine the effects of two K+ exchange resins: KX and calcium polystyrene sulfonate (RC) on Na+, K+, and Ca2+. Infant formula powder (Similac PM 60/40, Ross Laboratories, Columbus, OH, USA) was prepared with deionized water (DW) and KX or RC (1 g/mEq of K+) was added. The formula was decanted after 50 minutes and Na+, K+, and Ca2+ were assayed in the supernatant. Na+ and K+ were also assayed in ready-to-feed PM 60/40 (RTF). KX decreased the K+ concentration by 4.5 fold (P < 0.001) and increased the Na+ content by 3.8 fold (P < 0.001). In RC there was a 1.6-fold increase in Ca2+ content (P < 0.001), and a 13% decrease in K+ concentrations (P < 0.05). Preparation of the formula with DW reduced the K+ concentration by 30% compared to ready-to-feed formula (P < 0.001). We conclude that, although KX significantly reduces the K+ content of formulas, DW may be a more practical and convenient method of preparing formula for the hyperkalemic infant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10649740

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  8 in total

1.  Renal formulas pretreated with medications alters the nutrient profile.

Authors:  Jacob M Taylor; Leah Oladitan; Susan Carlson; Jill M Hamilton-Reeves
Journal:  Pediatr Nephrol       Date:  2015-05-01       Impact factor: 3.714

2.  Nutritional management of the infant with chronic kidney disease stages 2-5 and on dialysis.

Authors:  Vanessa Shaw; Caroline Anderson; An Desloovere; Larry A Greenbaum; Dieter Haffner; Christina L Nelms; Fabio Paglialonga; Nonnie Polderman; Leila Qizalbash; José Renken-Terhaerdt; Stella Stabouli; Jetta Tuokkola; Johan Vande Walle; Bradley A Warady; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2022-04-05       Impact factor: 3.714

3.  Pretreatment of infant formula with sodium polystyrene sulfonate : focus on optimal amount and contact time.

Authors:  Jean-Christy F Cameron; Dana Kennedy; Janusz Feber; Elaine Wong; Pavel Geier; Régis Vaillancourt
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

4.  Dietary phosphorus reduction by pretreatment of human breast milk with sevelamer.

Authors:  Elizabeth Ferrara; Jacques Lemire; Vivian M Reznik; Paul C Grimm
Journal:  Pediatr Nephrol       Date:  2004-04-22       Impact factor: 3.714

Review 5.  Optimizing Enteral Nutrition for Growth in Pediatric Chronic Kidney Disease (CKD).

Authors:  Christina L Nelms
Journal:  Front Pediatr       Date:  2018-08-02       Impact factor: 3.418

Review 6.  The dietary management of potassium in children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.

Authors:  An Desloovere; José Renken-Terhaerdt; Jetta Tuokkola; Vanessa Shaw; Larry A Greenbaum; Dieter Haffner; Caroline Anderson; Christina L Nelms; Michiel J S Oosterveld; Fabio Paglialonga; Nonnie Polderman; Leila Qizalbash; Bradley A Warady; Rukshana Shroff; Johan Vande Walle
Journal:  Pediatr Nephrol       Date:  2021-03-17       Impact factor: 3.714

7.  Pretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice.

Authors:  Krisha Le Palma; Elisha Rampolla Pavlick; Lawrence Copelovitch
Journal:  Clin Kidney J       Date:  2017-12-21

8.  Let food be thy medicine and medicine be thy food?

Authors:  Madelena Stauss; Beng So; Ben Reynolds
Journal:  Clin Kidney J       Date:  2018-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.